Hospital sales representative responsible for launching Kengreal, an IV P2Y12 inhibitor (anti platelet) in the cardiac catheterization lab, and re-launching Cleviprex, an IV dihydropiridine calcium channel blocker to control blood pressure in the acute setting. Cleviprex is primarily used in the cardiac surgical setting and the Neuro ICU.

Hospital Sales Specialist responsible for selling Integrilin, an IV GP2B3A inhibitor (antiplatelet), for use in Percutaneous Coronary Intervention procedures in the Cardiac Catheterization Lab. Launched Zontivity, an oral Par 1 inhibitor (antiplatelet) for the prevention of secondary events for post MI or PAD patients. Sold Zetia and Vytorin, indicated for the reduction of LDL. Call points included Interventional and Clinical Cardiologists, Emergency Room physicians, Nurse Practitioners, and… Show more Hospital Sales Specialist responsible for selling Integrilin, an IV GP2B3A inhibitor (antiplatelet), for use in Percutaneous Coronary Intervention procedures in the Cardiac Catheterization Lab. Launched Zontivity, an oral Par 1 inhibitor (antiplatelet) for the prevention of secondary events for post MI or PAD patients. Sold Zetia and Vytorin, indicated for the reduction of LDL. Call points included Interventional and Clinical Cardiologists, Emergency Room physicians, Nurse Practitioners, and Hospital Pharmacists. Show less